Abstract
Background Inflammation plays an important role in all the stages of atherosclerotic plaque development. The current study aimed at assessing the altered expression of genes functioning in inflammation within the early stage (ES)and advanced stage (AS) atherosclerotic plaques obtained from patients undergoing coronary artery bypass grafting (CABG) surgery and identifying biomarker panel/sthat may detect the status of plaque stages using peripheral blood samples.
Methods A section of ES and ASplaques and normal left internal mammary arteries (LIMA) were obtained from 8 patients undergoing theCABG surgery. Total RNA isolated was analysed for mRNA and miRNAexpression profile by Affymetrix arrays. Significant number of mRNAs was found to be differentially expressed in ES and ASplaque tissues relative to LIMA. The pathway analysis of differentially expressed mRNAs in the two plaque stages was also performed using DAVID Bioinformatics Database.
Results The mRNAs were found to be involved in critical inflammatory processes such as Toll-like receptor signalling pathway and cytokine-cytokine receptor interaction. Few miRNAs targeting these mRNAs were also altered in the two plaque conditions. QRT-PCR results showedsimilar expression pattern of few of themRNAs and miRNAsin peripheral blood of same patients relative to healthy controls.
Conclusion Changes in mRNA and miRNA expression associated with various inflammatory processes occur in different atherosclerotic stage plaques as well as peripheral blood. Detection of such variations in patients’ blood can be used as a possible prognostic tool to detect and/or predict the risk and stage of atherosclerosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Ethics Committee All India Institute of Medical Sciences New Delhi
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest: The authors declare that they do not have anything to disclose regarding conflict of interest with respect to this manuscript.
Data Availability
Raw data are available from the European Bioinformatics Institute ArrayExpress data repository (accession number-E-MTAB-10052 (mRNA data); E-MTAB-10051 (miRNA data)).
https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-10052/
https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-10051/
